My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    2.

    Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics.

    Gonçalves A, Braguer D, Kamath K, Martello L, Briand C, Horwitz S, Wilson L, Jordan MA.

    Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11737-42. Epub 2001 Sep 18.PMID: 11562465 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells.

    Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H.

    Biochem Pharmacol. 2002 Mar 15;63(6):1149-58.PMID: 11931848 [PubMed - indexed for MEDLINE]Related articles

    4.

    Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.

    Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, Wong YC.

    Oncogene. 2004 Jan 15;23(2):474-82.PMID: 14724576 [PubMed - indexed for MEDLINE]Related articles

    5.

    Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.

    Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP.

    FEBS Lett. 1998 Nov 20;439(3):368-72.PMID: 9845355 [PubMed - indexed for MEDLINE]Related articles

    6.

    BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.

    Kamath K, Wilson L, Cabral F, Jordan MA.

    J Biol Chem. 2005 Apr 1;280(13):12902-7. Epub 2005 Feb 6.PMID: 15695826 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Taxol suppresses dynamics of individual microtubules in living human tumor cells.

    Yvon AM, Wadsworth P, Jordan MA.

    Mol Biol Cell. 1999 Apr;10(4):947-59.PMID: 10198049 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line.

    Murphy L, Henry M, Meleady P, Clynes M, Keenan J.

    Biochim Biophys Acta. 2008 Sep;1784(9):1184-91. Epub 2008 May 1.PMID: 18503785 [PubMed - indexed for MEDLINE]Related articles

    9.

    Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.

    Yan XD, Li M, Yuan Y, Mao N, Pan LY.

    Oncol Rep. 2007 May;17(5):1163-9.PMID: 17390060 [PubMed - indexed for MEDLINE]Related articles

    10.

    Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells.

    Zhang X, Wang Q, Ling MT, Wong YC, Leung SC, Wang X.

    Int J Cancer. 2007 May 1;120(9):1891-8.PMID: 17230521 [PubMed - indexed for MEDLINE]Related articles

    11.

    Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.

    Peng X, Li W, Tan G.

    Anticancer Drugs. 2010 Apr;21(4):381-8.PMID: 20051827 [PubMed - in process]Related articles

    12.

    The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells.

    Lu M, Xiao L, Li Z.

    J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):725-8.PMID: 18231754 [PubMed - in process]Related articles

    13.

    Taxol: mechanisms of action and resistance.

    Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP.

    J Natl Cancer Inst Monogr. 1993;(15):55-61. Review.PMID: 7912530 [PubMed - indexed for MEDLINE]Related articles

    14.

    Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol.

    Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, Riker AI, Kamarajugadda S, Lu J, Owen LB, Ledoux SP, Tan M.

    Mol Cancer. 2010 Feb 9;9:33.PMID: 20144215 [PubMed - in process]Related articlesFree article

    15.

    The transport and binding of taxol.

    Parekh H, Simpkins H.

    Gen Pharmacol. 1997 Aug;29(2):167-72. Review.PMID: 9251895 [PubMed - indexed for MEDLINE]Related articles

    16.

    Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

    Donnelly A, Blagg BS.

    Curr Med Chem. 2008;15(26):2702-17. Review.PMID: 18991631 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.

    Lu M, Xiao L, Hu J, Deng S, Xu Y.

    J Huazhong Univ Sci Technolog Med Sci. 2008 Aug;28(4):451-5. Epub 2008 Aug 15.PMID: 18704310 [PubMed - in process]Related articles

    18.

    A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.

    Ishibashi M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N, Fukumoto M, Miyazaki K.

    Clin Cancer Res. 2008 May 15;14(10):3149-55.PMID: 18483383 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin.

    Umezu T, Shibata K, Kajiyama H, Terauchi M, Ino K, Nawa A, Kikkawa F.

    Int J Gynecol Pathol. 2008 Apr;27(2):207-12.PMID: 18317222 [PubMed - indexed for MEDLINE]Related articles

    20.

    Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.

    Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH.

    Oncol Rep. 2009 Jul;22(1):65-71.PMID: 19513506 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk